| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J1602 |
Injection, golimumab, 1 mg, for intravenous use |
1,188 |
426 |
$192K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,862 |
2,186 |
$67K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
674 |
430 |
$12K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
938 |
391 |
$5K |
| 99215 |
Prolong outpt/office vis |
35 |
24 |
$963.86 |
| 20611 |
|
23 |
12 |
$384.62 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
141 |
123 |
$309.66 |
| G2064 |
Comprehensive care management services for a single high-risk disease, e.g., principal care management, at least 30 minutes of physician or other qualified health care professional time per calendar month with the following elements: one complex chronic condition lasting at least 3 months, which is the focus of the care plan, the condition is of sufficient severity to place patient at risk of hospitalization or have been the cause of a recent hospitalization, the condition requires development or revision of disease-specific care plan, the condition requires frequent adjustments in the medication regimen, and/or the management of the condition is unusually complex due to comorbidities |
23 |
19 |
$206.64 |